Skip to main content

Table 1 Timeline

From: Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation

Dates

Relevant Past Medical History and Interventions

13/11/2016

A full-term AGA neonate, by third-degree cousins, born by spontaneous vaginal delivery, after a normal pregnancy. No remarkable obstetric and family history. Discharged home at the 3rd DOL.

Dates

Summaries from Initial and Follow-up Visits

Diagnostic Testing (including dates)

Interventions

21/11/2016

During paediatrician’s visit because of poor feeding and lethargy, the neonate had a cardiorespiratory arrest.

 

High quality cardiopulmonary resuscitation (30:2, single rescuer) for 3 minutes with reappearance of vital signs.

21/11/2016

Admission at NICU-Policlinico of Bari (Italy): significant weight loss, lethargy, hypotonia and absent tendon reflexes.

Severe hypercalcemia (28.7 mg/dl; RR: 8.6 ± 11.8 mg/dl), high serum alkaline phosphatase activity (663 U/L; RR: 105÷410 U/L), hyperparathyroidism (PTH 465 pg/ml; RR: 6.5÷36.8 pg/ml), hypophosphatemia (2 mg/dl; RR: 3.1÷7.7 mg/dl), normal magnesium (2.2 mg/dl; RR 1.8–2.4 mg/dl), normal 25-hydroxyvitamin D (33.1 pg/ml; RR: 19.8 ± 79.3 pg/ml).

Low calcium intake (85 mg/day), intravenous fluid hyperhydration (glucose solution 8% with aminoacids and physiologic solution - 220 ml/kg/day), Furosemide (2 mg/kg/day), Clodronate (1 mg/kg/day): No response (after 7 days of therapy)

26/11/2016

Persistent severe hypercalcemia, polyuria, dehydration, hypotonia, bone changes and failure to thrive.

Total body X-rays (skeletal undermineralization, subperiosteal bone resorption). ECG (anomalies of the recovery phase,“QT stretching”). Abdominal, cerebral and cardiac ultrasound (normal).

Parathyroid glands Ultrasound: glands not detectable.

Cinacalcet (0.4 mg/kg/day):

No response (after 2 weeks of treatment).

No adverse reactions.

05/12/2016

Both parents were clinically and biochemically normal.

Genomic DNA of proband and parents extracted from peripheral blood leukocytes and molecular screening of the Calcium-sensing receptor (CASR) gene (Sanger sequencing).

Proband: a novel autosomal recessive mutation in the CaSR gene: (c.1608 + 1G > A –IVS5 + 1G > A in homozygosity).

Parents: presence of the CaSR variant in heterozygosity (FHH clinical state).

13/12/2016

She was transferred to the NICU department of the G. Gaslini Institute of Genova (Italy).

Total calcium level stabilized around 6 mEq/L (equal to 12 mg/dl).

Increasing doses of Cinalcalcet (up to 4 mg/kg/day), low orally calcium intake (45 mg/day), intravenous fluid hyperhydration (up to 220 ml/kg/day).

20/12/2016

She was transferred to the Pediatric Surgery Unit of the G. Gaslini Institute of Genova (Italy).

Parathyroid glands Ultrasound: glands detectable by only the day before surgery.

Subtotal parathyroidectomy: three-excised hyperplastic parathyroid glands (5 × 3, 1.5 × 1.4 and 1.4 × 1.2 mm, respectively).

22/12/2016

Two days after surgery: transient asymptomatic hypocalcemia appeared (hungry bone syndrome).

X-rays of the right arm: pathological fracture of the humerus neck.

Daily Calcium gluconate replacement (0,5 ml/kg) and α-Calcidol (0,05 mcg/kg) for 40 days.

31/01/2017

Slow and progressive improvement of clinical conditions and hypocalcaemia.

 

Stop-therapy 40 days post-surgery (Calcium gluconate and α-Calcidol).

 

A longer and personalized follow up started in order to confirm if the partial parathyroidectomy was sufficient for calcium balance or a second surgical approach is needed.